col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Food and Chemical Toxicology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―10 Recent Advances in Potential Drug Therapies Combating COVID-19 and Related Coronaviruses-A Perspective Shivraj Hariram Nile, Arti Nile, Shivkumar Jalde, Guoyin Kai
2 [GO] 2021―May―21 SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis Yijun Wang, Jinbao Huang, Yong Sun, David Stubbs, Jun He, Weiwei Li, et al. (+7)
3 [GO] 2021―Apr―24 SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats Zhangqiong Huang, Qinfang Jiang, Yixuan Wang, Jinling Yang, Tingfu Du, Hongkun Yi, et al. (+16)
4 [GO] 2021―Apr―08 Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors? Saraiya Tanmay, Dimitrios Lambros, Konstantinos Farsalinos, Konstantinos Poulas
5 [GO] 2021―Apr―03 Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads Gaurav Joshi, Jayant Sindhu, Shikha Thakur, Abhilash Rana, Geetika Sharma, Ramarao Poduri
6 [GO] 2021―Mar―29 The effects of some essential and toxic metals/metalloids in COVID-19: A review Jose L. Domingo, Montse Marquès
7 [GO] 2021―Mar―18 Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update Gaurav Joshi, Shikha Thakur, Ramarao Poduri
8 [GO] 2021―Feb―25 Inflammation, immunity and potential target therapy of SARS-COV-2: a total scale analysis review Shukur Wasman Smail, Muhammad Saeed, Zhikal Omar Khudhur, Delan Ameen Younus, Mustafa Fahmi Rajab, Wayel Habib Abdulahad, et al. (+3)
9 [GO] 2021―Jan―24 Nicotinic Cholinergic System and COVID-19: In Silico Identification of Interactions Βetween α7 Nicotinic Acetylcholine Receptor and the Cryptic Epitopes of SARS-Co-V and SARS-CoV-2 Spike Glycoproteins George Lagoumintzis, Christos T. Chasapis, Nikolaos Alexandris, Dimitrios Kouretas, Socrates Tzartos, Elias Eliopoulos, et al. (+2)
10 [GO] 2021―Jan―23 Corrigendum to “Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases” [Food Chem. Toxicol. 146 111809] Anatoly V. Skalny, Thania Rios Rossi Lima, Tao Ke, Ji-Chang Zhou, Julia Bornhorst, Svetlana I. Alekseenko, et al. (+6)
11 [GO] 2021―Jan―23 Immunotoxic role of Organophosphates: an unseen risk escalating SARS-CoV-2 pathogenicity Prem Rajak, Abhratanu Ganguly, Saurabh Sarkar, Moutushi Mandi, Moumita Dutta, Sayanti Podder, et al. (+2)
12 [GO] 2021―Jan―19 Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: implication of herb-drug interactions in COVID-19 pharmacotherapy Feng Zhang, Jian Huang, Wei Liu, Chao-Ran Wang, Yan-Fang Liu, Dong-Zhu Tu, et al. (+5)
14 [GO] 2021―Jan―04 Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - an in silico study Shanmugaraj Gowrishankar, Sankar Muthumanickam, Arumugam Kamaladevi, Chandrasekar Karthika, Ravi Jothi, Pandi Boomi, et al. (+2)
15 [GO] 2020―Nov―27 Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update Shikha Thakur, Bibekananda Sarkar, Arshad J. Ansari, Akanksha Khandelwal, Anil Arya, Ramarao Poduri, Gaurav Joshi
16 [GO] 2020―Oct―16 Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases Anatoly V. Skalny, Thania Rios Rossi Lima, Tao Ke, Ji-Chang Zhou, Julia Bornhorst, Svetlana I. Alekseenko, et al. (+6)
17 [GO] 2020―Oct―08 Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic Dimitrios Vlachakis, Eleni Papakonstantinou, Thanasis Mitsis, Katerina Pierouli, Io Diakou, George Chrousos, Flora Bacopoulou
18 [GO] 2020―Oct―01 SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 Aristides Tsatsakis, Daniela Calina, Luca Falzone, Dimitrios Petrakis, Radu Mitrut, Vasileios Siokas, et al. (+14)
19 [GO] 2020―Sep―21 Comprehensive Assessment of Side Effects in COVID-19 Drug Pipeline from a Network Perspective Qihui Wu, Xiude Fan, Honghai Hong, Yong Gu, Zhihong Liu, Shuhuan Fang, et al. (+3)
20 [GO] 2020―Sep―08 Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management. Georgios Mavraganis, Evmorfia Aivalioti, Sofia Chatzidou, Raphael Patras, Ioannis Paraskevaidis, Ioannis Kanakakis, et al. (+2)
21 [GO] 2020―Aug―26 Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19 Reza Jahromi, Vahid Mogharab, Hossein Jahromi, Arezoo Avazpour
22 [GO] 2020―Aug―18 Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19 Ignatios Ikonomidis, George Pavlidis, Pelagia Katsimbri, Vaia Lambadiari, John Parissis, Ioanna Andreadou, et al. (+4)
23 [GO] 2020―Aug―14 The Under-Reported Role of Toxic Substance Exposures in the COVID-19 Pandemic Ronald N. Kostoff, Michael B. Briggs, Alan L. Porter, Antonio F. Hernández, Mohammad Abdollahi, Michael Aschner, Aristidis Tsatsakis
24 [GO] 2020―Jul―21 An overview of safety assessment of the medicines currently used in the treatment of COVID-19 disease Dragana Javorac, Lazar Grahovac, Luka Manić, Nikola Stojilković, Milena Anđelković, Zorica Bulat, et al. (+3)
25 [GO] 2020―May―11 COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence Aristidis Tsatsakis, Demetrious Petrakis, Taxiarchis Konstantinos Nikolouzakis, Anca Oana Docea, Daniela Calina, Marco Vinceti, et al. (+5)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec